Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Cephalon, Inc.
Current Parent Company: Teva Pharmaceutical Industries
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $6,150,000
Year: 2008
Date: September 29, 2008
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Violation Description: Cephalon agreed to pay $6.15 million to settle allegations it marketed its drugs Actiq, Gabitril and Provigil for unapproved uses, leading to a huge increase in off-label prescription with significant health and safety risks. This was a separate Connecticut settlement in addition to the federal/multistate settlement.
Level of Government: state
Action Type: agency action
Agency: Connecticut Attorney General
Civil or Criminal Case: civil
Facility State: Connecticut
HQ Country of Current Parent: Israel
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.